Chen Yingxiao, Sun Xiao-Xin, Sears Rosalie C, Dai Mu-Shui
Departments of Molecular & Medical Genetics, School of Medicine, OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Genes Dis. 2019 Jul 24;6(4):359-371. doi: 10.1016/j.gendis.2019.05.006. eCollection 2019 Dec.
The transcription factor c-MYC (MYC thereafter) controls diverse transcription programs and plays a key role in the development of many human cancers. Cells develop multiple mechanisms to ensure that MYC levels and activity are precisely controlled in normal physiological context. As a short half-lived protein, MYC protein levels are tightly regulated by the ubiquitin proteasome system. Over a dozen of ubiquitin ligases have been found to ubiquitinate MYC whereas a number of deubiquitinating enzymes counteract this process. Recent studies show that SUMOylation and deSUMOylation can also regulate MYC protein stability and activity. Interestingly, evidence suggests an intriguing crosstalk between MYC ubiquitination and SUMOylation. Deregulation of the MYC ubiquitination-SUMOylation regulatory network may contribute to tumorigenesis. This review is intended to provide the current understanding of the complex regulation of the MYC biology by dynamic ubiquitination and SUMOylation and their crosstalk.
转录因子c-MYC(以下简称MYC)控制着多种转录程序,并在许多人类癌症的发展中起关键作用。细胞发展出多种机制,以确保在正常生理环境中MYC的水平和活性受到精确调控。作为一种半衰期较短的蛋白质,MYC蛋白水平受到泛素蛋白酶体系统的严格调控。已发现十几种泛素连接酶可使MYC泛素化,而许多去泛素化酶则抵消这一过程。最近的研究表明,SUMO化和去SUMO化也可以调节MYC蛋白的稳定性和活性。有趣的是,有证据表明MYC泛素化和SUMO化之间存在着引人入胜的相互作用。MYC泛素化-SUMO化调控网络的失调可能导致肿瘤发生。本综述旨在提供对通过动态泛素化和SUMO化及其相互作用对MYC生物学进行复杂调控的当前理解。